Acquired BRAF V600E Mutation as Resistant Mechanism after Treatment with Third-Generation EGFR Tyrosine Kinase Inhibitor
- PMID: 29074209
- DOI: 10.1016/j.jtho.2017.07.017
Acquired BRAF V600E Mutation as Resistant Mechanism after Treatment with Third-Generation EGFR Tyrosine Kinase Inhibitor
Comment on
-
Acquired BRAF V600E Mutation as Resistant Mechanism after Treatment with Osimertinib.J Thorac Oncol. 2017 Mar;12(3):567-572. doi: 10.1016/j.jtho.2016.11.2231. Epub 2016 Dec 5. J Thorac Oncol. 2017. PMID: 27923714
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
